{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T19:13:23Z","timestamp":1795115603670,"version":"4.10.3"},"reference-count":61,"publisher":"American Society of Hematology","issue":"16","license":[{"start":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T00:00:00Z","timestamp":1714003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8,27]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Hemolytic disease of fetus and newborn (HDFN) is a life-threatening disease mediated by maternal alloimmunization to red blood cell (RBC) antigens. Studies of maternal alloimmunization prevalence in the United States lack national data. This study describes prevalence and trends in alloimmunization in pregnancy in the United States. RBC antibodies (abs) were identified in a large, nationwide, commercial laboratory database from 2010 through 2021. The cohort comprised pregnancies for which the year of laboratory collection and patient\u2019s state of residence were available. Data were normalized based on US Centers for Disease Control and Prevention estimates of live births and weighted by year and US Census Division. Cochrane-Armitage tests assessed temporal trends of alloimmunization. Of 9\u2009876 196 pregnancies, 147\u2009262 (1.5%) screened positive for RBC abs, corresponding to an estimated prevalence of 1518 of 100\u2009000 pregnancies. Of identified RBC abs, anti-D comprised 64.1% pregnancies (586\/100\u2009000). Prevalence of other high-risk RBC abs for HDFN included anti-K (68\/100\u2009000) and anti-c (29\/100\u2009000). Incidence of all 3 high-risk abs increased from 2010 to 2021 (all P\u00a0&amp;lt; .001). Among almost 10 million pregnancies in the United States, comprising an estimated 14.4% of all pregnancies, 1.5% screened positive for RBC abs. Almost three-quarters (679\/100\u2009000 [74.3%]) of RBC abs identified were high risk for HDFN. Although prevalence of anti-D is difficult to interpret without the ability to distinguish alloimmunization from passive immunity, it remains problematic in HDFN, ranking second only to anti-K in critical titers. Given the sequelae of HDFN, new initiatives are required to reduce the incidence of alloimmunization in patients of reproductive potential.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023012241","type":"journal-article","created":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T13:17:42Z","timestamp":1714051062000},"page":"4311-4319","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":44,"title":["Maternal red blood cell alloimmunization prevalence in the United\u00a0States"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9379-5540","authenticated-orcid":false,"given":"Ronan P.","family":"Sugrue","sequence":"first","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Moise","sequence":"additional","affiliation":[{"name":"2Department of Women\u2019s Health, Dell Medical School \u2013 The University of Texas at Austin, Austin, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0321-6280","authenticated-orcid":false,"given":"Jerome J.","family":"Federspiel","sequence":"additional","affiliation":[{"name":"1Department of Obstetrics and Gynecology, Duke University School of Medicine, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5526-966X","authenticated-orcid":false,"given":"Elizabeth","family":"Abels","sequence":"additional","affiliation":[{"name":"3Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy Z.","family":"Louie","sequence":"additional","affiliation":[{"name":"4Quest Diagnostics, Secaucus, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Chen","sequence":"additional","affiliation":[{"name":"4Quest Diagnostics, Secaucus, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance","family":"Bare","sequence":"additional","affiliation":[{"name":"4Quest Diagnostics, Secaucus, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian P.","family":"Alagia","sequence":"additional","affiliation":[{"name":"4Quest Diagnostics, Secaucus, NJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2850-9047","authenticated-orcid":false,"given":"Harvey W.","family":"Kaufman","sequence":"additional","affiliation":[{"name":"4Quest Diagnostics, Secaucus, NJ"},{"name":"5Department of Pediatrics, Boston Children's Hospital, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"issue":"4","key":"2024090917355574900_bib1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tmrv.2016.05.008","article-title":"Hemolytic disease of the fetus and newborn: modern practice and future investigations","volume":"30","author":"Hendrickson","year":"2016","journal-title":"Transfus Med Rev"},{"issue":"2","key":"2024090917355574900_bib2","doi-asserted-by":"crossref","first-page":"100203","DOI":"10.1016\/j.xagr.2023.100203","article-title":"Live birth prevalence of hemolytic disease of the fetus and newborn in the United States from 1996 to 2010","volume":"3","author":"Yu","year":"2023","journal-title":"AJOG Glob Rep"},{"issue":"9","key":"2024090917355574900_bib3","first-page":"825","article-title":"Isoimmunization in pregnancy: its possible bearing on the etiology of erythroblastosis foetalis","volume":"116","author":"Levine","year":"1941","journal-title":"J\u00a0Am Med Assoc"},{"key":"2024090917355574900_bib4","volume-title":"The blood group antigen factsbook","author":"Reid","year":"2012"},{"issue":"5","key":"2024090917355574900_bib5","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/AOG.0b013e31826d7dc1","article-title":"Management and prevention of red cell alloimmunization in pregnancy: a systematic review","volume":"120","author":"Moise","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2024090917355574900_bib6","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1182\/asheducation-2015.1.146","article-title":"Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn","volume":"2015","author":"Delaney","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"24","key":"2024090917355574900_bib7","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1001\/jama.1991.03460240066029","article-title":"Epidemiology of Rh hemolytic disease of the newborn in the United States","volume":"265","author":"Ch\u00e1vez","year":"1991","journal-title":"JAMA"},{"issue":"1","key":"2024090917355574900_bib8","first-page":"8","article-title":"The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh (D) alloimmunisation","volume":"8","author":"Liumbruno","year":"2010","journal-title":"Blood Transfus"},{"issue":"2","key":"2024090917355574900_bib9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/trf.15631","article-title":"Diagnostic value of laboratory monitoring to predict severe hemolytic disease of the fetus and newborn in non-D and non-K-alloimmunized pregnancies","volume":"60","author":"Koelewijn","year":"2020","journal-title":"Transfusion"},{"issue":"2","key":"2024090917355574900_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/0973-6247.137449","article-title":"Hemolytic disease of fetus and newborn due to maternal red blood cell alloantibodies in the Malay population","volume":"8","author":"Hassan","year":"2014","journal-title":"Asian J Transfus Sci"},{"issue":"7","key":"2024090917355574900_bib11","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/j.1537-2995.2010.03006.x","article-title":"Severe hemolytic disease of fetus and newborn caused by red blood cell antibodies undetected at first-trimester screening (CME)","volume":"51","author":"Dajak","year":"2011","journal-title":"Transfusion"},{"issue":"50","key":"2024090917355574900_bib12","first-page":"2523","article-title":"The incidence of irregular antibodies in pregnancy: a prospective study in the region of the's-Hertogenbosch","volume":"143","author":"De Vrijer","year":"1999","journal-title":"Ned Tijdschr Geneeskd"},{"issue":"2","key":"2024090917355574900_bib13","first-page":"1","article-title":"Prevalence of red blood cell alloantibodies in pregnant women and hemolytic disease of newborn in a tertiary care hospital","volume":"2","author":"Solves","year":"2017","journal-title":"ARC J Gynecol Obs"},{"issue":"3","key":"2024090917355574900_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/tme.12511","article-title":"RBC alloantibody prevalence and specificity in a Western Norwegian tertiary hospital","volume":"29","author":"Erikstein","year":"2019","journal-title":"Transfus Med"},{"issue":"2","key":"2024090917355574900_bib15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/PAT.0000000000000225","article-title":"Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia","volume":"47","author":"Pal","year":"2015","journal-title":"Pathology"},{"issue":"4","key":"2024090917355574900_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-3148.2003.00445.x","article-title":"Prevalence and specificity of clinically significant red cell alloantibodies in Chinese women during pregnancy\u2013a review of cases from 1997 to 2001","volume":"13","author":"Lee","year":"2003","journal-title":"Transfus Med"},{"issue":"11","key":"2024090917355574900_bib17","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1111\/trf.14262","article-title":"Red blood cell alloimmunization in pregnancy during the years 1996-2015 in Iceland: a nation-wide population study","volume":"57","author":"Bollason","year":"2017","journal-title":"Transfusion"},{"issue":"9","key":"2024090917355574900_bib18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/S1701-2163(15)30148-1","article-title":"Alloimmune red blood cell antibodies: prevalence and pathogenicity in a Canadian Prenatal population","volume":"37","author":"Zwingerman","year":"2015","journal-title":"J\u00a0Obstet Gynaecol Can"},{"issue":"4","key":"2024090917355574900_bib19","doi-asserted-by":"crossref","first-page":"127","DOI":"10.21307\/immunohematology-2019-134","article-title":"Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility","volume":"29","author":"Smith","year":"2013","journal-title":"Immunohematology"},{"key":"2024090917355574900_bib20","first-page":"283","article-title":"Prevalence and specificity of clinically significant red cell alloantibodies in pregnant women - a study from a tertiary care hospital in Southeast Michigan","volume":"10","author":"Moinuddin","year":"2019","journal-title":"J\u00a0Blood Med"},{"key":"2024090917355574900_bib21","first-page":"171","article-title":"Capture-R ready-ID and DiaMed-ID for identification of erythrocyte bound antibodies after acid elution","volume":"34","author":"Beck","year":"1997","journal-title":"Beitr Infusionsther Transfusionsmed"},{"key":"2024090917355574900_bib22","volume-title":"Seminars in Fetal and Neonatal Medicine","year":"2016"},{"issue":"2","key":"2024090917355574900_bib23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-3148.2006.00655.x","article-title":"Comparison of three microtube column agglutination systems for antibody screening: DG Gel, DiaMed-ID and Ortho BioVue","volume":"16","author":"Cid","year":"2006","journal-title":"Transfus Med"},{"issue":"12","key":"2024090917355574900_bib24","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1111\/aogs.14261","article-title":"Management and clinical consequences of red blood cell antibodies in pregnancy: a population-based cohort study","volume":"100","author":"Liu","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"2024090917355574900_bib25","first-page":"25","article-title":"Obstetric management in Rh alloimmunizated pregnancy","volume":"3","author":"Cacciatore","year":"2009","journal-title":"J Prenat Med"},{"key":"2024090917355574900_bib26","author":"Avery","year":"2005"},{"issue":"4","key":"2024090917355574900_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ajog.2018.07.020","article-title":"Predicting anti-Kell-mediated hemolytic disease of the fetus and newborn: diagnostic accuracy of laboratory management","volume":"219","author":"Slootweg","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"2024090917355574900_bib28","author":"Center for Disease Control and Prevention","year":"2021"},{"issue":"9","key":"2024090917355574900_bib29","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.2105\/AJPH.83.9.1289","article-title":"CDC WONDER: a comprehensive on-line public health information system of the centers for disease control and prevention","volume":"83","author":"Friede","year":"1993","journal-title":"Am J Public Health"},{"issue":"7","key":"2024090917355574900_bib30","first-page":"1","article-title":"Estimated pregnancy rates and rates of pregnancy outcomes for the United States, 1990-2008. national vital statistics reports: from the centers for disease control and prevention, National Center for Health Statistics","volume":"60","author":"Ventura","year":"2012","journal-title":"Natl Vital Stat Rep"},{"key":"2024090917355574900_bib31","unstructured":"Kost\n              K\n            , Maddow-ZimetI, LittleAC. Pregnancies and pregnancy desires at the state level: estimates for 2017 and trends since 2012. Accessed 3 August 2023. https:\/\/www.guttmacher.org\/report\/pregnancy-desires-and-pregnancies-state-level-estimates-2017."},{"issue":"1","key":"2024090917355574900_bib65","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/tme.12743","article-title":"Evaluating automated titre score as an alternative to continuous flow analysis for the prediction of passive anti-D in pregnancy","volume":"31","author":"Evans","year":"2021","journal-title":"Transfus Med"},{"issue":"9","key":"2024090917355574900_bib66","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1537-2995.2006.00924_1.x","article-title":"On the immunologic basis of Rh immune globulin (anti-D) prophylaxis","volume":"46","author":"Kumpel","year":"2006","journal-title":"Transfusion"},{"key":"2024090917355574900_bib38","first-page":"25","author":"Vespa","year":"2018"},{"key":"2024090917355574900_bib39","volume-title":"Statistics OoHS","author":"US Department of Homeland Security","year":"2022"},{"issue":"20","key":"2024090917355574900_bib33","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1182\/bloodadvances.2021005361","article-title":"Blood transfusion trends in the United States: national inpatient sample, 2015 to 2018","volume":"5","author":"Goel","year":"2021","journal-title":"Blood Adv"},{"issue":"suppl 2","key":"2024090917355574900_bib34","first-page":"S1","article-title":"Slowing decline in blood collection and transfusion in the United States\u20132017","volume":"60","author":"Jones","year":"2020","journal-title":"Transfusion"},{"issue":"9","key":"2024090917355574900_bib35","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1111\/trf.13644","article-title":"Declining blood collection and utilization in the United States","volume":"56","author":"Chung","year":"2016","journal-title":"Transfusion"},{"issue":"12","key":"2024090917355574900_bib40","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1046\/j.1537-2995.2001.41121539.x","article-title":"Autologous blood transfusion in the United States: clinical and nonclinical determinants of use","volume":"41","author":"Segal","year":"2001","journal-title":"Transfusion"},{"issue":"6","key":"2024090917355574900_bib41","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1016\/S2352-3026(23)00066-2","article-title":"Alloimmunisation against red blood cells in sickle cell disease: transfusion challenges in high-income and low-income countries","volume":"10","author":"Pirenne","year":"2023","journal-title":"Lancet Haematol"},{"issue":"21","key":"2024090917355574900_bib42","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/bloodadvances.2018018408","article-title":"Antibody-mediated immune suppression by antigen modulation is antigen-specific","volume":"2","author":"Maier","year":"2018","journal-title":"Blood Adv"},{"issue":"10","key":"2024090917355574900_bib43","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1002\/pd.4419","article-title":"Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women\u20142 years of screening experience from Denmark","volume":"34","author":"Banch Clausen","year":"2014","journal-title":"Prenat Diagn"},{"key":"2024090917355574900_bib44","doi-asserted-by":"crossref","first-page":"i5789","DOI":"10.1136\/bmj.i5789","article-title":"Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands","volume":"355","author":"De Haas","year":"2016","journal-title":"BMJ"},{"issue":"8","key":"2024090917355574900_bib45","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1111\/trf.16552","article-title":"Blood transfusions in gunshot-wound-related emergency department visits and hospitalizations in the United States","volume":"61","author":"Goel","year":"2021","journal-title":"Transfusion"},{"issue":"1","key":"2024090917355574900_bib46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/voxs.12617","article-title":"Rh disease prevention: the European perspective","volume":"16","author":"Toly-Ndour","year":"2021","journal-title":"ISBT Sci Ser"},{"issue":"5","key":"2024090917355574900_bib47","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ajcp\/aqad083","article-title":"Updates in the care of the alloimmunized pregnant patient : a transfusion medicine and clinical laboratory perspective","volume":"160","author":"Abels","year":"2023","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2024090917355574900_bib48","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0301-2115(00)00428-0","article-title":"Non-anti-D antibodies in red-cell alloimmunization","volume":"92","author":"Moise","year":"2000","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"3","key":"2024090917355574900_bib50","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1111\/trf.16276","article-title":"Reduction of anti-K-mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: a nation-wide policy change evaluation study in the Netherlands","volume":"61","author":"Luken","year":"2021","journal-title":"Transfusion"},{"issue":"2","key":"2024090917355574900_bib51","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3889\/oamjms.2017.054","article-title":"The impact of extended typing on red blood cell alloimmunization in transfused patients","volume":"5","author":"Makarovska-Bojadzieva","year":"2017","journal-title":"Open Access Maced J Med Sci"},{"issue":"2","key":"2024090917355574900_bib52","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/trf.13347","article-title":"Incidence of alloantibody formation after ABO-D or extended matched red blood cell transfusions: a randomized trial (MATCH study)","volume":"56","author":"Schonewille","year":"2016","journal-title":"Transfusion"},{"issue":"1","key":"2024090917355574900_bib53","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vox.12455","article-title":"Prophylactic RhCE and Kell antigen matching: impact on alloimmunization in transfusion-dependent patients with myelodysplastic syndromes","volume":"112","author":"Lin","year":"2017","journal-title":"Vox Sang"},{"issue":"5","key":"2024090917355574900_bib54","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/bjh.15182","article-title":"Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS-III) database","volume":"181","author":"Karafin","year":"2018","journal-title":"Br J Haematol"},{"key":"2024090917355574900_bib55","unstructured":"US Census Bureau\n          . National population by characteristics: 2020-2023. Accessed 2 November 2023. https:\/\/www.census.gov\/data\/datasets\/time-series\/demo\/popest\/2020s-national-detail.html."},{"issue":"20","key":"2024090917355574900_bib56","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1182\/bloodadvances.2022006982","article-title":"Red cell alloimmunization is associated with increased health care costs, longer hospitalizations, and higher mortality","volume":"6","author":"Viayna","year":"2022","journal-title":"Blood Adv"},{"issue":"3","key":"2024090917355574900_bib57","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/trf.12941","article-title":"It\u2019s time to phase-in RHD genotyping for patients with a serological weak D phenotype","volume":"55","author":"Sandler","year":"2015","journal-title":"Transfusion"},{"issue":"4","key":"2024090917355574900_bib58","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/bjh.17697","article-title":"The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation","volume":"195","author":"Oud","year":"2021","journal-title":"Br J Haematol"},{"issue":"10","key":"2024090917355574900_bib59","first-page":"CD002042","article-title":"Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion","volume":"10","author":"Carson","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2024090917355574900_bib60","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jtha.2023.09.025","article-title":"Doing more with less: low-titer group O whole blood resulted in less total transfusions and an independent association with survival in adults with severe traumatic hemorrhage","volume":"22","author":"Shea","year":"2024","journal-title":"J\u00a0Thromb Haemost"},{"issue":"1","key":"2024090917355574900_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bja\/aev165","article-title":"Fit to fly\u2019: overcoming barriers to preoperative haemoglobin optimization in surgical patients","volume":"115","author":"Mu\u00f1oz","year":"2015","journal-title":"Br\u00a0J Anaesth"},{"issue":"10","key":"2024090917355574900_bib62","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1111\/trf.14925","article-title":"Blood utilization and mortality in victims of gun violence","volume":"58","author":"DeMario","year":"2018","journal-title":"Transfusion"},{"issue":"5","key":"2024090917355574900_bib63","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/ip.2004.008094","article-title":"Comparison of fatalities from work related motor vehicle traffic incidents in Australia, New Zealand, and the United States","volume":"11","author":"Driscoll","year":"2005","journal-title":"Inj Prev"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/16\/4311\/2241114\/blooda_adv-2023-012241-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/16\/4311\/2241114\/blooda_adv-2023-012241-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T13:36:39Z","timestamp":1725888999000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/16\/4311\/515897\/Maternal-red-blood-cell-alloimmunization"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":61,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2024,8,27]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023012241","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]}}}